MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-2.83 Cr | ₹-2.52 Cr | ₹-1.88 Cr | ₹-0.50 Cr | ₹0.28 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MEDICAMEN BIOTECH ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-2.83 Cr |
Mar2024 | ₹-2.52 Cr |
Mar2023 | ₹-1.88 Cr |
Mar2022 | ₹-0.50 Cr |
Mar2021 | ₹0.28 Cr |
How is Deferred Tax Assets / Liabilities of MEDICAMEN BIOTECH Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-2.83 Cr | Negative | |
Mar2024 | ₹-2.52 Cr | Negative | |
Mar2023 | ₹-1.88 Cr | Negative | |
Mar2022 | ₹-0.50 Cr | Negative | |
Mar2021 | ₹0.28 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹437.9 Cr | -2.2% | -7% | -29.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,727.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | -2.2% |
-7% |
-29.7% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses